A detailed history of Endurance Wealth Management, Inc. transactions in Synlogic, Inc. stock. As of the latest transaction made, Endurance Wealth Management, Inc. holds 21,900 shares of SYBX stock, worth $31,317. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,900
Previous 11,900 84.03%
Holding current value
$31,317
Previous $8,000 62.5%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$0.42 - $0.68 $4,200 - $6,800
10,000 Added 84.03%
21,900 $3,000
Q4 2022

Feb 01, 2023

BUY
$0.58 - $17.99 $6,901 - $214,080
11,900 New
11,900 $9,000
Q1 2022

Apr 20, 2022

SELL
$1.63 - $2.55 $7,986 - $12,495
-4,900 Closed
0 $0
Q1 2021

May 05, 2021

BUY
$2.2 - $5.05 $10,780 - $24,745
4,900 New
4,900 $18,000

Others Institutions Holding SYBX

# of Institutions
2
Shares Held
25.5K
Call Options Held
0
Put Options Held
0

About SYNLOGIC, INC.


  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $100M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Endurance Wealth Management, Inc. Portfolio

Follow Endurance Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Endurance Wealth Management, Inc. with notifications on news.